R. Byhardt

发表

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

W. Curran, C. Gwede, K. Fu, 2000, International journal of radiation oncology, biology, physics.

Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.

H. Sandler, J. Speight, T. Pisansky, 2011, The journal of sexual medicine.

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31)

W. Sause, G. Hanks, M. Rotman, 1996 .

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

A H Russell, R. Komaki, L. Gaspar, 1998, International journal of radiation oncology, biology, physics.

Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer.

T. Pajak, W. Sause, J. Cox, 1997, Lung cancer.

Weekly localization films and detection of field placement errors.

J. Cox, R. Byhardt, A. Hornburg, 1978, International journal of radiation oncology, biology, physics.

Local control and survival after external irradiation for adenocarcinoma of the prostate.

J. Cox, R. Byhardt, J. Wilson, 1981, International journal of radiation oncology, biology, physics.

The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma.

James B. Nickson, W. Hong, R. Finney, 1979, The Journal of urology.

Radiotherapy: Is Conventional Dose Fractionation Necessary?

V. Semenenko, R. Byhardt, C. Schultz, 2012 .

Results of whole-brain irradiation for metastases from small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1980, Cancer treatment reports.

Pathologic Stage Is Most Prognostic of Disease-free Survival in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiation

R. Byhardt, 2009 .

The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.

M. Graham, C. Perez, B. Emami, 2003, Lung cancer.

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.

R. Komaki, W. Sause, B. Emami, 1998, International journal of radiation oncology, biology, physics.

The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1984, Seminars in oncology.

Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease

R. Byhardt, J. Ruckdeschel, P. Wiernik, 1975, Cancer.

Radiotherapy Patterns of Care Study in Lung Carcinoma

D. Ettinger, R. Abrams, R. Munden, 2003 .

Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.

W. Curran, M. Graham, J. Cox, 1992, Journal of the National Cancer Institute.

Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?

C. Lawton, R. Byhardt, J. Wilson, 1994, Radiology.

102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis

M. Graham, C. Perez, B. Emami, 1996 .

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

J. Cooper, B. Emami, V. Vaitkevicius, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study.

J. Cooper, R. Pazdur, R. Byhardt, 1988, International journal of radiation oncology, biology, physics.

Ki-67 staining is a strong predictor of patient outcome for prostate cancer patients treated with androgen deprivation plus radiotherapy: an analysis of RTOG 92–02

H. Sandler, M. Desilvio, W. Shipley, 2003 .

Characteristics of long‐term survivors after treatment for inoperable carcinoma of the lung

Hongyung Choi, J. Cox, R. Komaki, 1985, American journal of clinical oncology.

Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.

W. Curran, R. Komaki, W. Sause, 2000, Radiology.

Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).

J. Cox, A. Hartz, R. Byhardt, 1986, International journal of radiation oncology, biology, physics.

Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01

D. Ettinger, D. Johnstone, C. Scott, 2002 .

Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410

W. Curran, S. Hauser, W. Sause, 2000 .

The association of adult respiratory distress syndrome (ARDS) with thoracic irradiation (RT).

R. Abrams, R. Byhardt, U. Almagro, 1988, International journal of radiation oncology, biology, physics.

Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Spinal cord metastasis in small cell carcinoma of the lung.

R. Byhardt, U. Almagro, P. Holoye, 1984, International journal of radiation oncology, biology, physics.

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90‐15

D. Ettinger, W. Curran, C. Scott, 1995, Cancer.

RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate

S. Rosenthal, G. Hanks, V. Venkatesan, 2000 .

95 Phase III trial of adjuvant androgen suppression using goserelin in patients with carcinoma of the prostate treated with definitive radiotherapy (results of RTOG 85-31)

G. Hanks, A. Porter, R. Byhardt, 1995 .

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

T. Pajak, J. Cooper, J. Beitler, 1997, International journal of radiation oncology, biology, physics.

Phase III radiation therapy oncology group (RTOG) trial 86-10 od androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate

D. Grignon, P. Rubin, W. Sause, 1998 .

Is long‐term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?

J. Cox, C. Lawton, R. Byhardt, 1992, Cancer.

Integration of chemotherapy and radiation therapy for small cell carcinoma of the lung.

J. Cox, R. Byhardt, P. Holoye, 1982, International journal of radiation oncology, biology, physics.

Dose-time relationships and the local control of small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1978, Radiology.

M. O’connell, R. Byhardt, J. Ruckdeschel, 1975, Medicine.

Coronary Artery Disease After Radiation Therapy for Hodgkin's Lymphoma: Coronary CT Angiography Findings and Calcium Scores in Nine Asymptomatic Patients

R. Byhardt, 2009 .

Randomized Study of Adjuvant Chemotherapy for Head and Neck Cancer

R. G. Hoffman, P. Ritch, R. Byhardt, 1985, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.

M. McAleer, R. Komaki, W. Sause, 2010, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)

W. Curran, R. Komaki, S. Hauser, 2000 .

Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer.

R. Byhardt, 1999, Oncology.

Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report.

J. Cox, A. Hartz, R. Byhardt, 1987, Archives of otolaryngology--head & neck surgery.

The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies

R. Hoffmann, J. Cox, P. Ritch, 1987, The Laryngoscope.

Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung.

J. Cox, R. Byhardt, J. Wilson, 1979, International journal of radiation oncology, biology, physics.

D. Ettinger, D. Johnstone, C. Scott, 2002, International journal of radiation oncology, biology, physics.

Can interferon beta make the radiation therapy team for treatment of non-small cell lung cancer?

R. Byhardt, 1993, International journal of radiation oncology, biology, physics.

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.

W. Sause, G. Hanks, M. Rotman, 1998, International journal of radiation oncology, biology, physics.

Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02.

B. Fisher, W. Sause, W. Kraybill, 2000, International journal of radiation oncology, biology, physics.

Do elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? a secondary analysis of RTOG 94-10

W. Curran, R. Komaki, W. Sause, 2001 .

Effect of advanced age on outcome in Radiation Therapy Oncology Group studies of locally advanced NSCLC (LA-NSCLC)

W. Curran, R. Komaki, W. Sause, 2000 .

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, International journal of radiation oncology, biology, physics.

Altered fractionation for non-small cell carcinoma of the lung. Rationale for the prospective trials of the Radiation Therapy Oncology Group.

K. Fu, W. Sause, C. Perez, 1989, Chest.

The radiation therapy oncology group experience altered fractionation in lung cancer

T. Pajak, W. Sause, B. Emami, 1993 .

Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes.

J. Cox, R. Byhardt, J. Cox, 1983, Cancer treatment reports.

247 Phase III study comparing chemotherapy and radiation therapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer (NSCLC) with spread to mediastinal lymph nodes (N2): A radiation therapy oncology group study (RTOG 89-01)

P. Rubin, D. Johnson, R. Byhardt, 1997 .

High‐dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi‐institutional trial (radiation therapy oncology group protocol 8801)

S. Wadler, R. Byhardt, S. Order, 1992, Cancer.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

L. Gaspar, K. Fu, B. Emami, 1997, International journal of radiation oncology, biology, physics.

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

J. Cooper, B. Emami, V. Vaitkevicius, 1992, The New England journal of medicine.

Superiority of combined chemoradiotherapy to radiotherapy alone in patients with esophageal cancers. An intergroup study

J. Cooper, B. Emami, V. Vaitkevicius, 1994 .

Significant adbantage of chemo-radiotherapy compared to radiation alone in randomized phase III trial for patients with esophageal cancer: An intergroup study

T. Pajak, J. Cooper, B. Emami, 1991 .

Recombinant Human Interferon-β (rHuIFN-β) and Radiation Therapy for Inoperable Non-Small Cell Lung Cancer

E. Borden, L. Vaickus, C. Lawton, 1996 .

Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes.

J. Cox, R. Komaki, R. Byhardt, 1983, Cancer treatment reports.

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol.

G. Ibbott, J. Michalski, M. Gillin, 2006, Brachytherapy.

Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma

D. Ettinger, R. Abrams, R. Munden, 2002 .

The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung.

J. Cox, R. Byhardt, P. Holoye, 1981, International journal of radiation oncology, biology, physics.

Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small‐cell carcinoma of the lung

J. Cox, R. Komaki, R. Byhardt, 1981, Cancer.

Extended‐Field Radiation Therapy for Prostatic Carcinoma with Para‐Aortic Lymph Node Metastasis

J. Cox, A. Hartz, C. Glisch, 1986, American journal of clinical oncology.

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol.

K. Shin, T. Pajak, B. Emami, 1993, International journal of radiation oncology, biology, physics.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.

R. Komaki, W. Sause, J. Cox, 1999, International journal of radiation oncology, biology, physics.

In reply [6]

B. Movsas, Colum J Smith, C. Langer, 2005 .

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

J. Cooper, M. Graham, S. Spencer, 1999, JAMA.

Turning up the heat on nonsmall cell lung cancer: is the toxicity of concurrent cisplatin-based chemotherapy and accelerated fractionation acceptable?

R. Byhardt, 1995, International journal of radiation oncology, biology, physics.

Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies.

T. Pajak, W. Sause, C. Perez, 1994, Lung cancer.

Recurrence patterns by treatment modality of carcinomas of the floor of the mouth and oral tongue.

R. Lehman, J. Cox, R. Byhardt, 1982, American journal of otolaryngology.

Patterns of failure and results of preoperative irradiation vs radiation therapy alone in carcinoma of the pyriform sinus.

J. Cox, R. Byhardt, 1980, International journal of radiation oncology, biology, physics.

Assessment of pain during head and neck irradiation.

N. Janjan, D. Weissman, R. Byhardt, 1989, Journal of pain and symptom management.

Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non–small-cell lung cancer

R. Byhardt, 2009 .

A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract.

R. Hoffmann, J. Cox, P. Ritch, 1986, International journal of radiation oncology, biology, physics.

1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531

D. Grignon, T. Pajak, G. Hanks, 1997 .

Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

R. Byhardt, R. W. Byhardt, 2009 .

The role of splenic irradiation in chronic lymphocytic leukemia

R. Byhardt, P. Wiernik, K. Brace, 1975, Cancer.

N2 (clinical) non-small cell carcinoma of the lung (NSCCL): Prospective trials of radiation therapy with total doses ≥ 60 GY by the radiation therapy oncology group (RTOG)

K. Shin, C. Perez, J. Cox, 1989 .

Alternate strategies for limited stage small cell lung cancer.

R. Byhardt, J. Wilson, 1990, International journal of radiation oncology, biology, physics.

Radiotherapy patterns of care study in lung carcinoma.

D. Ettinger, R. Abrams, R. Munden, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

What is the lowest effective biologic dose for prophylactic cranial irradiation?

J. Cox, R. Komaki, R. Byhardt, 1985, American journal of clinical oncology.

Complications of radiation therapy and factors in their prevention

J. Cox, R. Komaki, R. Byhardt, 1986, World Journal of Surgery.

Do "elderly fit" patients have less comorbidity?

E. Gore, R. Byhardt, S. Firat, 2003, International journal of radiation oncology, biology, physics.

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

D. Grignon, W. Shipley, G. Hanks, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinomas of the oropharynx treated with hyperfractionated radiation therapy on Radiation Therapy Oncology Group Protocol 8313.

S. McDonald, T. Pajak, K. Fu, 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Value of postoperative radiotherapy in patients with pathologic N1 neck disease

R. Byhardt, 2009 .

The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer

R. Byhardt, 2003 .

Microvessel Density ≥60 Does Not Predict for Outcome After Radiation Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: Results of a Correlative Study From the Radiation Therapy Oncology Group (RTOG) 90-03 Trial

Christopher U. Jones, K. Ang, M. Hammond, 2007, American journal of clinical oncology.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

R. Komaki, L. Gaspar, K. Fu, 1999 .

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.

W. Curran, S. McDonald, R. Komaki, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.

S. McDonald, T. Pajak, J. Cooper, 1994, International journal of radiation oncology, biology, physics.

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials.

T. Pajak, B. Emami, J. Cox, 1993, International journal of radiation oncology, biology, physics.

Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non‐small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83‐11

W. Curran, K. Shin, T. Phillips, 1991, Cancer.

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group.

K. Shin, C. Perez, B. Emami, 1991, International journal of radiation oncology, biology, physics.

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.

C. Perez, B. Emami, T. Wasserman, 1989, International journal of radiation oncology, biology, physics.

Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG.

C. Perez, B. Emami, L. Brady, 1988, International journal of radiation oncology, biology, physics.

Radiation-related pericarditis.

J. Ruckdeschel, R. Byhardt, J. Ruckdeschel, 1975, The American journal of cardiology.

Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.

Maria Werner-Wasik, Walter J Curran, W. Curran, 2011, Clinical lung cancer.

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol

K. Shin, T. Pajak, B. Emami, 1993 .

Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.

Benjamin Movsas, D. Ettinger, R. Komaki, 2005, International journal of radiation oncology, biology, physics.

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

R. Komaki, B. Movsas, Colum J Smith, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

W. Curran, P. Kolesar, R. Livingston, 2000 .

Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis.

W. Travis, R. Komaki, F. Fossella, 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.

L. True, R. Whittington, R. Byhardt, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.

E. Gore, R. Byhardt, S. Firat, 2002, International journal of radiation oncology, biology, physics.

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.

D. Ettinger, W. Curran, P. Rubin, 1997, International journal of radiation oncology, biology, physics.

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.

W. Curran, P. Kolesar, R. Livingston, 2001, Chest.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

W. Sause, B. Movsas, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.

W. Curran, R. Komaki, W. Sause, 2005, International journal of radiation oncology, biology, physics.

Interaction of thoracic irradiation and chemotherapy on local control and survival in small cell carcinoma of the lung.

J. Cox, R. Byhardt, J. Wilson, 1979, Cancer treatment reports.

Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1983, American journal of clinical oncology.

Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus

R. Byhardt, 2009 .

Advanced carcinoma of the nasopharynx

Z. Petrovich, J. Cox, R. Byhardt, 1982 .

Advanced carcinoma of the nasopharynx. A clinical study of 274 patients.

Z. Petrovich, J. Cox, R. Byhardt, 1982, Radiology.

A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial

M. O’connell, R. Byhardt, P. Wiernik, 1975, Cancer.

Development of a rat lung cancer model.

R. Byhardt, U. Almagro, B. Fish, 1984, International journal of radiation oncology, biology, physics.

The Role of Radiation Therapy in the Treatment of Recurrent Adult Laryngeal Papillomatosis

R. Byhardt, Unas Almagro, 1988, American Journal of Clinical Oncology.

P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.

Christopher U. Jones, K. Ang, K. Fu, 2003, International journal of radiation oncology, biology, physics.

Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.

W. Curran, R. Komaki, T. Pajak, 1993, Lung cancer.

Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?

V. Semenenko, R. Byhardt, C. Schultz, 2012, International journal of radiation oncology, biology, physics.

Brachytherapy of localized penile carcinoma.

R. Byhardt, J. Wilson, 1992, Cancer treatment and research.

The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies.

E. Gore, R. Byhardt, S. Firat, 2010, International journal of radiation oncology, biology, physics.

Age Is Independent of Comorbidity Influencing Patient Selection for Combined Modality Therapy for Treatment of Stage III Nonsmall Cell Lung Cancer (NSCLC)

E. Gore, R. Byhardt, S. Firat, 2006, American journal of clinical oncology.

Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

R. Komaki, B. Movsas, S. Swann, 2008, International journal of radiation oncology, biology, physics.

interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313

P. Rubin, T. Pajak, K. Fu, 1992, Cancer.

Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.

P. Rubin, T. Pajak, K. Fu, 1990, International journal of radiation oncology, biology, physics.

Tumor utilization committee

D. Grignon, M. Mehta, C. Willet, 2001 .

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

R. Komaki, B. Emami, J. Cox, 1997, American journal of clinical oncology.

Is adenocarcinoma/large cell carcinoma the most radiocurable type of cancer of the lung?

J. Cox, R. Komaki, A. Hartz, 1986, International journal of radiation oncology, biology, physics.

Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.

D. Ettinger, W. Curran, R. Abrams, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Kyounghwa Bae, Alan Pollack, D. Grignon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: Radical surgery versus radiotherapy for adenocarcinoma of the prostate.

S. Nag, R. Byhardt, B. Roswit, 1983, The Journal of urology.

Lung cancer committee

D. Ettinger, R. Munden, R. Komaki, 2001 .

The role of thoracic and cranial irradiation for small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1981, International journal of radiation oncology, biology, physics.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer.

R. Byhardt, 1995, International journal of radiation oncology, biology, physics.

109 RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable now small cell lung cancer with minimum three year follow-up

W. Curran, R. Komaki, R. Livingston, 1995 .

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07.

T. Pajak, B. Emami, R. Doggett, 1993, International journal of radiation oncology, biology, physics.

Phase II Trial of Combination Chemotherapy and Irradiation in Non‐Small‐Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

J. Cooper, W. Sause, R. Lindberg, 1992, American journal of clinical oncology.

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.

P. Rubin, T. Pajak, K. Fu, 1995, International journal of radiation oncology, biology, physics.

Adjuvant Treatments do not Alter the Quality of Life in Elderly Patients With Colorectal Cancer: A Population-based Study

R. Byhardt, 2009 .

Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.

K. Ang, K. Fu, J. Beitler, 1995, International journal of radiation oncology, biology, physics.

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.

M. Bousamra, E. Gore, R. Byhardt, 2002, International journal of radiation oncology, biology, physics.

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

M. Hammond, H. Sandler, K. Bae, 2009, Clinical Cancer Research.

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.

M. Roach, R. Byhardt, C. Scott, 1999, International journal of radiation oncology, biology, physics.

Computed tomography in the staging of small cell lung cancer: implications for combined modality therapy.

J. Cox, W. Foley, G. Unger, 1985, International Journal of Radiation Oncology, Biology, Physics.

Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q-Twist) in locally advanced non-Small cell lung cancer (LA-NSCLC)-a radiation therapy oncology group (RTOG) analysis

R. Komaki, W. Sause, B. Movsas, 2000 .

Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06.

J. Earle, P. Rubin, W. Sause, 1998, International journal of radiation oncology, biology, physics.

P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.

W. Curran, R. Komaki, W. Sause, 2000, Radiology.

Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients

T. Pajak, B. Emami, J. Cox, 1992 .

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.

W. Curran, W. Sause, B. Emami, 1997, International journal of radiation oncology, biology, physics.

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma.

W. A. Gardner, R. Finney, C. Olsson, 1982, The Journal of urology.

The prognostic significance of histologic subtyping in small cell carcinoma of the lung

J. Cox, R. Byhardt, U. Almagro, 1984, American journal of clinical oncology.

Local control of squamous carcinoma of oral cavity and oropharynx with 3 vs 5 treatment fractions per week.

J. Cox, R. Byhardt, M. Greenberg, 1977, International journal of radiation oncology, biology, physics.

Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.

J. Cox, R. Komaki, R. Byhardt, 1980, International Journal of Radiation Oncology, Biology, Physics.

Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis

W. Curran, R. Komaki, W. Sause, 2005 .

Combined methotrexate and high‐dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma

J. Cox, R. Byhardt, T. Anderson, 1985, Cancer.

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90‐15

D. Ettinger, W. Curran, C. Scott, 1995, Cancer.

Brain metastasis in patients with superior sulcus tumors

J. Cox, A. Hartz, R. Byhardt, 1987, Cancer.

Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801

Benjamin Movsas, Nicos Nicolaou, R. Komaki, 2007 .

Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01)

J. Cooper, M. Graham, S. Spencer, 1999 .

The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer

R. Byhardt, 2003 .

Radiotherapeutic management of non-small cell lung cancer(NSCLC). An overview based on the clinical trials of the radiation therapy oncology group(RTOG).:AN OVERVIEW BASEDON THE CHNICAL TRIALS OF THE RADIATION THERAPY ONCOLOGY GROUP (RTOG)

R. Byhardt, J. Wilson, W. Roger, 1995 .